Goldman Sachs Group »

Iteos Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.1M 742k 10.95
2023-09-30 $6.7M 609k 10.95
2023-06-30 $8.5M 644k 13.24
2023-03-31 $6.0M 438k 13.61
2022-12-31 $8.3M 427k 19.53
2022-06-30 $8.5M 411k 20.60
2022-03-31 $5.9M 183k 32.18
2021-12-31 $5.5M 117k 46.56
2021-09-30 $4.7M 175k 27.00
2021-03-31 $2.3M 67k 34.18
2020-12-31 $2.1M 61k 33.81
2020-09-30 $652k 26k 24.67